Senior Director of Business Development shares insight on industry trends and outsourcing.

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.

Wheeler Bio has partnered with Mitsubishi Corporation to expand its commercial reach and business development activities across the Asia-Pacific region.

Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials, in a cash transaction valued at $8.875 billion.

SK pharmteco and Lotte Biologics have signed a Letter of Intent for a strategic collaboration to strengthen their competitiveness in the global ADC market.

New plate-based multiplexing unlocks ultra-high-sample and cell-throughput single cell analysis to empower a broad range of studies.

Symbiosis Pharmaceutical Services, a global CMO specializing in the sterile manufacture of injectable drug products, has strengthened its business development team in the U.S. with the appointments of ...

VP of Operations shares insight on biologics and opportunities in the solid dose space.

Will leverage PolyPeptide’s peptide manufacturing and development services and Lifecore’s formulation, fill/finish, and packaging services.

BioCina, a pharmaceutical contract development and manufacturing organization (CDMO), has appointed Dr. Thomas Broudy as CEO.

To combine TruCytes Biomarker Controls with the Cell Q platform to enhance quality and automation.